Stable solid medicinal composition for oral administration

Details for Australian Patent Application No. 2004208617 (hide)

Owner Yamanouchi Pharamaceutical Co., Ltd.

Inventors Yasuji, Takehiko; Nishida, Akito; Niwa, Akira; Atsuta, Yutaka; Sugihara, Akio; Masaki Katsuhiro

Agent Davies Collison Cave

Pub. Number AU-A-2004208617

PCT Pub. Number WO2004/066998

Priority 2003-023500 31.01.03 JP

Filing date 30 January 2004

Wipo publication date 12 August 2004

Acceptance publication date 13 September 2007

International Classifications

A61K 031/4184

A61K 009/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 009/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 047/02 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 047/12 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 047/14 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 047/18 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 047/22 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61K 047/30 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 047/38 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 025/00 Drugs for disorders of the nervous system

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 403/06 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 February 2005 PCT application entered the National Phase

  PCT publication WO2004/066998 Priority application(s): WO2004/066998

18 August 2005 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 07 Jun 2005

22 December 2005 Assignment before Grant

  Yamanouchi Pharmaceuticals Co., Ltd. The application has been assigned to Astellas Pharma Inc.

13 September 2007 Application Accepted

  Published as AU-A-2004208617

29 November 2007 Application for Amendment

  The nature of the amendment is: Delete the name of co-inventors Nishida, Akito; Niwa, Akira and Atsuta, Yutaka. Add the name of co-inventors Sugihara, Akio; Masaki, Katsuhiro and Yasuji, Takehiro. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

20 March 2008 Amendment Made

  The nature of the amendment is: Amend the named inventors to read Sugihara, Akio; Masaki Katsuhiro and Yasuji, Takehiko

10 April 2008 Standard Patent Sealed

23 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004208619-Solid/liquid separation method for continuously extracting and/or pressing edible food or drink

2004208615-Medicine for prevention of and treatment for arteriosclerosis and hypertension